PHD2/HDACs-IN-1

Overview

PHD2/HDACs-IN-1 is a potent PHD2 / HDACs hybrid inhibitor ( IC 50 s of 1.15 μM, 19.75 μM, 26.60 μM and 15.98 μM for PHD2, HDAC1 , HDAC2 and HDAC6 , respectively). PHD2/HDACs-IN-1 is a low-toxicity renoprotective agent for research of cisplatin-induced acute kidney injury (AKI).

Application

Products | Products > Disease Areas > Cancer | Products > Signaling Pathways > Cell Cycle/DNA Damage | Products > Signaling Pathways > Epigenetics | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Signaling Pathways > HDAC | Products > Signaling Pathways > HIF/HIF Prolyl-Hydroxylase

Product Information

• Catalog No.: HY-144332
• CAS No.: 2339867-53-5
• Molecular Formula: C18H19N9O4
• Molecular Weight: 425.40
• Purity: 99.98%
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.

Source

Original product source